A Hybrid PET/MRI Probe for Simultaneous Quantitative In Vivo Imaging of Extracellular Lactate and Tumor Perfusion

Summarise with VIRAT
Authors: Remy Chiaffarelli, Jan Kretschmer, L. Trefftz, Tjark Kelm, S. Mueller, Y. Al-Moufleh, M. Ghaderian, J. Cotton, M. Zimmermann, S. Matějková, M. Polasek, A. Schmid
+1 more A. Martins
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: The tumor microenvironment is a complex network in which biological abnormalities converge, often leading to poor perfusion and accumulation of metabolic byproducts. Extracellular lactate (lactatee) is a key regulator of tumor progression and therapy response, yet remains difficult to quantify in vivo.[1] To address this need, we developed q-Lac-1, a hybrid PET/MRI probe that enables simultaneous, quantitative imaging of tissue perfusion and extracellular lactate using PET and CEST. We report the first quantitative lactatee and perfusion maps in a preclinical metastatic breast cancer model. Methods: q-Lac-1 was radiofluorinated via nucleophilic aromatic substitution and used to prepare a 18/19F reference solution of known chemical and activity concentration. PET/MR imaging was performed in a 7T scanner (Bruker BioSpec) and a PET insert. CEST of phantoms with lactate and q-Lac-1 titrations were recorded at different pH and B1 values to determine lactate responsiveness, affinity constants (KA), and exchange rates (kex). 15 mice were implanted with two PyMT-derived breast cancer cell lines, S2WTP3 (parental) and ML1B1B1 (metastatic), with different growth rates (Fig.2A,B). Perfusion maps (time-to-peak, wash-in/-out) and q-Lac-1 concentration were derived from PET images. Lactatee maps were obtained by combining the CEST effect (40 ppm) and q-Lac-1 concentration (Fig.1H). Results/Discussion: Phantom CEST imaging showed that q-Lac-1 can detect lactate by shifting its -OH resonance in biologically relevant concentration ranges, producing CEST effects at 15 and 40 ppm that depend on both lactate and probe concentration (Fig. 1B-E). We labelled q-lac-1 with 18F to directly track its concentration using PET, overcoming probe concentration–dependent artifacts. Biodistribution analysis with a gamma counter, ICP-OES, and dynamic PET showed quick renal excretion of the probe (Fig. 1F,G). Such kinetics were then used to determine different tumor perfusion parameters (Fig. 1H). In vivo imaging showed better perfusion in S2WTP3 tumors, but no significant differences in lactatee levels compared to ML1B1B1 (Fig. 2C-E). However, intra-model comparison of tumors at earlier (< 150 mm3) and later (> 150 mm3) stages showed significantly higher lactate levels in smaller tumors, with no differences in perfusion (Fig. 2F-H). Conclusion: Simultaneous PET/CEST MRI with [18F]q-Lac-1 enables quantitative in vivo mapping of perfusion and extracellular lactate. Applied to metastatic breast cancer models, this approach revealed distinct metabolic phenotypes and staging dependent lactate accumulation, highlighting the value of combined metabolic and perfusion readouts for probing metabolic tumor microenvironment heterogeneity and associated aggressiveness.

Fields of Study & Subjects

Medical Imaging Techniques and Applications Advanced MRI Techniques and Applications Radiopharmaceutical Chemistry and Applications

Publication details

Journal / source
MPG.PuRe (Max Planck Society)
Publication date
1 January 2026
Language
EN